Inhibitory activity of acetylcholinesterase by 18 extracts Guatemala native plant species used in the treatment of nervous disorders
Keywords:
Lantana camara, Tagetes lucida, Valeriana prionophylla, Wigandia urens var. caracasana, Lippia graveolens, Chaptalia mutansAbstract
Abstract
Neurodegenerative syndromes generate memory and behavior deterioration, usually in the elderly.The most common is Alzheimer´s disease, which is associated with decreased levels of acetylcholine(ACh) after an increase of acetylcholinesterase (AChE). Worldwide studies have described somesecondary metabolites from plants that might inhibit the enzyme activity or retard neuronal deterioration.With the aim of finding inhibitors of AChE, activity was evaluated in extracts (dichloromethane andmethanol) of 18 medicinal and aromatic plants used in Guatemala for nervous or memory disorders(Brugmansia candida, Cassia reticulata, Chaptalia nutans, Chiranthodendron pentadactylon, Dorsteniacontrajerva, Erythrina berteroana, Lantana camara, Lippia graveolens, Petiveria alliacea, Phlebodiumpseudoaureum, Pimenta dioica, Salvia microphylla, Solanum nigrescens, Tagetes lucida, Ternstroemiatepezapote, Valeriana prionophylla, Vernonia deppeana and Wigandia urens var. caracasana). AChEinhibition was assessed qualitatively by two bioautographic TLC assays and quantitatively by akinetic microcolorimetric evaluation. The results demonstrated activity by bioautography in all speciesat screening concentration (5 μl), but when quantified by microcolorimetry no significant activity(>50%) was demonstrated at 1 mg/mL. Three of the species with shown activity (L. camara, T. lucidaand V. prionophylla) were partitioned to see if the liquid:liquid partions presented more activity, butthis did not increase the activity. Intermediate activity was also found in extracts from C. nutans, D.contrajerva var. houstoni, L. graveolens and W. urens var. caracasana. Studies will continue regardingthe antioxidant activity in order to determine whether there might be some potential use.
Keywords:
Lantana camara, Tagetes lucida, Valeriana prionophylla, Wigandia urens var. caracasana,Lippia graveolens, Chaptalia nutans.
References
Referencias
Adams, M., Gmünder, F. & Hamburger, M.
(2007). Plants traditionally used in age
related brain disorders - A survey of
ethnobotanical literature. Journal of
Ethnopharmacology, 111, 363-381.
Adsersen, A., Gaugin, B., Gudiksen, L. & Jäger,
A.K. (2006). Screening of plants used in
Danish folk medicine to treat memory
dysfunction for acetylcholinesterase
inhibitory activity. Journal of
Ethnopharmacology, 104, 418-422.
Akhondzadeh, S. & Abassi, S.H. (2006). Herbal
medicine in the treatment of Alzheimer’s
disease. American Journal of Alzheimer’s
Disease and Other Dementias, 21, 113-
Barbosa Filho, J.M., Medeiros, K.C.P., Diniz,
M.F.F.M., Batista, L.M., Athayde-Filho,
P.F., Silva, M.S. et al. (2006). Natural
products inhibitors of the enzyme
acetycholinesterase. Brazilian Journal of
Pharmacognosy 16, 258-285.
Calderón. A.I., Cubilla, M., Espinosa, A. &
Gupta, M.P. (2010). Screening of plants
of Amaryllidaceae and related families
from Panama as sources of
acetylcholinesterase inhibitors.
Pharmaceutical Biology. 48, 988-
Carpinella, M.C., Andrione, D.G., Ruiz, G. &
Palacios, S.M. (2010). Screening for
acetylcholinesterase inhibitory activity in
plant extracts from Argentina.
Phytotherapy Research, 24, 259-263.
Chopra, K., Misra, B. & Kuhad, A. (2011).
Current perspectives on pharmacotherapy
of Alzheimer’s disease. Expert Opinion
in Pharmacotherapy, 12, 335-350.
Ellman, G.L., Courtney, K.D., Andres, V. &
Featherstone, R.M. (1961). A new and
rapid colorimetric determination of
acetylcholinesterase activity. Biochemistry
Pharmacology, 7, 88-95
Figueiró, M., Ilha, J., Pochmann, D., Porciúncula,
L.O., Xavier, L.L., Achaval, M. et al.
(2010). Acetylcholinesterase inhibition in
cognition-relevant brain areas of mice
treated with a nootropic Amazonian herbal
(Marapuama). Phytomedicine. 17, 956-
Houghton, P.J., Ren, Y. & Howes, M.J. (2006).
Acetylcholinesterase inhibitors from plants
and fungi. Natural Products Report, 23,
-199.
Howes, M.J. & Perry, E. (2011). The role of
phytochemicals in the treatment and
prevention of dementia. Drugs Aging, 28,
-468.
Kalaria, R.J., Maestre, G.E., Arizaga, R.,
Friedland, R.F., Galasko, D., Hall, K. et
al. (2008). Alzheimer’s disease and
vascular dementia in developing countries:
prevalence, management, and risk factors.
Lancet Neurology, 7, 812-826.
Kim, J., Lee, H.J. & Lee, K.W. (2010). Naturally
occurring phytochemicals for the
prevention of Alzheimer’s disease. Journal
of Neurochememistry, 112, 1415-1430.
Marco, L. & Carreiras, C.C. (2006).
Galanthamine, a natural product for the
treatment of Alzheimer’s disease. Recent
Patents in CNS Drug Discovery, 1, 105-
Marston, A., Kissling, I. & Hostettmann, K.
(2002). A rapid TLC bioautography
method for the detection of
a c e t y l c h o l i n e s t e r a s e a n d
butyrylcholinesterase inhibitors in plants.
Phytochemistry Analysis, 13, 51-54.
Mosquera, O.M., Niño, J., Correa, Y.M. &
Hernández, J.A. (2004). Detección in vitro
de inhibidores de la acetilcolinesterasa en
extractos de cuarenta plantas de la flora
colombiana mediante el método
cromatográfico de Ellman. Scientia et
Technica, 10, 155-160.
Peng, S. & Zhao, M. (2009). Pharmaceutical
Bioassays. Methods and Applications.
Hoboken, NJ:John Wiley & Sons, Inc..
p (pp. 129).993.
Perry, E. & Howes, M.J.R. (2010). Medicinal
plants and dementia therapy: Herbal hopes
for brain aging? CNS Neuroscience
Therapy, 17, 1-16
Rubinsztein, D.C. (2006). The roles of
intracellular protein-degradation pathways
in neurodegeneration. Nature, 443,
–786.
Siqueira, I.R., Fochesatto, C., da Silva, A.L.,
Nunes, D.S., Battastini, A.M., Netto, C.A.
& Elisabetsky, E. (2003). Ptychopetalum
olacoides, a traditional Amazonian “nerve
tonicâ€, possess anticholinesterase activity.
Pharmacology, Biochemistry & Behavior,
, 645-650.
Vinutha, B., Prashanth, D., Salma, K., Sreeja,
S.L., Pratti, D., Padmaja, R. et al. (2007).
Screening of selected Indian medicinal
plants for acetylcholinesterase inhibitory
activity. Journal of Ethnopharmacology,
, 359-363.
Yang, Z., Zhang, X., Duan, D., Song, Z., Yang,
M. & Li, S. (2009). Modified TLC
bioautographic method for screening
acetylcholinesterase inhibitors from plant
extracts. Journal of Separation Science.
, 3257-3259.
Wilkinson, D. (2007). Pharmacotherapy of
Alzheimer’s disease. Psychiatry, 7, 9-14.